In addition, other families of amplification events, such as FGFR2 amplification and activation of other FGFR mutations, have been associated with the maintenance of tumour-initiating cells as well as high sensitivity to FGFR inhibitors. This evidence concerns the gene FGFR2 and neoplasm.